Comprehensive and Detailed Explanation From Exact Extract-Based NCC C-EFM References:
Whenever a fetal heart rate is unexpectedly low (such as 90 bpm), the FIRST step per NCC and AWHONN is to confirm that the signal is fetal, not maternal.
Even internal spiral electrodes can capture maternal heart rate, especially after:
* Rupture of membranes
* Maternal hypotension
* Maternal dehydration
* Maternal tachycardia or bradycardia
Thus, the first, most immediate action is:
# Palpate the maternal radial pulse to determine whether the tracing is maternal or fetal.
If rates match # the monitor is falsely detecting the maternal pulse.
If rates differ # confirm true fetal bradycardia and begin intrauterine resuscitation.
Why the other options are incorrect:
* A. Intrauterine resuscitation - should NOT begin before confirming the tracing is fetal.
* C. Bedside ultrasound - appropriate after confirming that the tracing is not maternal, not before.
Correct answer: B. Palpation of the maternal radial pulse.
References:NCC C-EFM Candidate Guide; AWHONN FHMPP; Menihan; Miller's Pocket Guide; Simpson
& Creehan.

Comprehensive and Detailed Explanation From Exact Extract-Based NCC C-EFM References:
Maternal hyperthermia-most commonly from infection-causes a rise in fetal temperature, which increases fetal metabolic rate. The fetus responds by increasing heart rate to meet the increased oxygen demand.
Effects include:
* Increased fetal oxygen consumption
* Enhanced fetal cardiac output
* Resultant tachycardia, often 160-180 bpm
This mechanism is repeatedly outlined in NCC's physiology domain, AWHONN, Menihan, Simpson, and Creasy & Resnik.
Option A is incorrect because maternal fever does not reduce perfusion.
Option C is incorrect because catecholamines are often elevated, not inhibited.
Thus, the mechanism is increased fetal metabolism.
References:NCC C-EFM Candidate Guide; NCC Physiology Domain; AWHONN Fetal Heart Monitoring Principles & Practices; Menihan Electronic Fetal Monitoring; Simpson & Creehan Perinatal Nursing; Creasy
& Resnik Maternal-Fetal Medicine.

Comprehensive and Detailed Explanation From Exact Extract (No URLs)
For fetuses before 32-34 weeks, the National Certification Corporation (NCC) follows the physiologic standards established by AWHONN, Simpson & Creehan, Menihan, and Creasy & Resnik, which emphasize that preterm fetuses have less mature autonomic nervous system development, resulting in smaller and shorter accelerations.
According to the NCC C-EFM Exam Content Outline (Pattern Recognition & Intervention) and the AWHONN Fetal Heart Monitoring Principles (2022-2024):
* Preterm fetuses (<32 weeks) normally demonstrate 10 bpm × 10 sec accelerations.
* By approximately 32-34 weeks, accelerations may begin transitioning toward 15×15, but the accepted standard for documentation at 34 weeks remains 10×10, unless clearly meeting 15×15 criteria.
* NCC emphasizes using gestational-age-appropriate criteria for documenting accelerations, because autonomic reactivity increases gradually and is not fully comparable to term until after
32-34 weeks.
Menihan's Electronic Fetal Monitoring also states that preterm fetuses "should be evaluated with the
10×10 rule until it is clear that the fetus is demonstrating mature 15×15 acceleratory capacity." Simpson & Creehan reinforce this point, noting that accelerations in late preterm gestations "may not consistently reach 15 bpm for 15 seconds, and thus 10×10 remains the appropriate designation." Since the patient is 34 weeks, the fetus is late-preterm and may not reliably meet the full 15×15 criteria; therefore, the correct documentation standard remains 10×10.
Thus, accelerations should be charted as:
"Present 10×10."
References
* NCC C-EFM Candidate Guide 2025 - Content Domain: Pattern Recognition and Intervention
* AWHONN Fetal Heart Monitoring Principles & Practices, 2022-2024
* Menihan: Electronic Fetal Monitoring: Concepts and Applications
* Simpson & Creehan: Perinatal Nursing
* Miller: Fetal Monitoring Pocket Guide
* Creasy & Resnik: Maternal-Fetal Medicine

Comprehensive and Detailed Explanation From Exact Extract-Based NCC C-EFM References:
Sustained fetal supraventricular tachycardia (SVT) often produces heart rates > 200-240 bpm, causing:
* Poor ventricular filling
* Decreased stroke volume
* Reduced cardiac output
* Congestive heart failure
* Progressive fluid accumulation
NCC and AWHONN emphasize that untreated SVT leads to hydrops fetalis, characterized by:
* Ascites
* Pleural effusion
* Pericardial effusion
* Skin edema
Why the other answers are incorrect:
* A. Fetal anemia - Causes tachycardia but is not caused by SVT.
* C. Neonatal pacemaker - Pacemakers treat heart block, not SVT.
Correct answer: B. Hydrops fetalis
References:NCC C-EFM Candidate Guide; AWHONN Principles & Practices; Simpson & Creehan; Creasy
& Resnik Maternal-Fetal Medicine.

Comprehensive and Detailed Explanation From Exact Extract-Based NCC C-EFM References:
Assessment of likely fetal acid-base status is grounded in NCC-aligned principles that correlate fetal pH with fetal heart rate patterns, especially variability, presence/absence of accelerations, and type and depth of decelerations.
This tracing shows the following features:
Baseline:
The fetal heart rate baseline is approximately 140-150 bpm, within the normal 110-160 bpm range.
Variability:
Moderate variability is present-approximately 6-25 bpm amplitude.
Per NCC and NICHD definitions, moderate variability is strongly associated with normal fetal oxygenation and normal fetal pH > 7.20-7.25.
Accelerations:
There are occasional small accelerations, another strong indicator of normal fetal acid-base status.
Decelerations:
The tracing shows occasional variable decelerations, shallow and brief, recovering rapidly, typical of intermittent cord compression.
NCC references emphasize that intermittent, non-recurrent variables with moderate variability do not correlate with acidemia.
Uterine activity:
Contractions are present but not excessive, and fetal response remains reassuring.
Correlating tracing features with fetal pH (per NCC, AWHONN, Simpson, Menihan):
Moderate variability is the strongest intrapartum indicator of normal fetal pH.
The NICHD/NCC consensus repeatedly states that:
"The presence of moderate variability reliably predicts adequate fetal oxygenation and a fetal pH above the threshold associated with metabolic acidemia." Fetal pH below 7.15 is associated with:
Absent variability
Recurrent late decelerations
Recurrent deep variable decelerations
Prolonged bradycardia
None are present in this tracing.
Because the tracing demonstrates moderate variability, intermittent uncomplicated variables, and no recurrent late decelerations, the physiologic expectation is that the fetal pH remains normal, significantly above 7.15.
Therefore, the correct answer is: A (above 7.15).
References:
NCC C-EFM Candidate Guide (2025); NCC Content Outline; NICHD Interpretation System; AWHONN Fetal Heart Monitoring Principles & Practices; Miller's Fetal Monitoring Pocket Guide; Menihan Electronic Fetal Monitoring; Simpson & Creehan Perinatal Nursing; Creasy & Resnik Maternal-Fetal Medicine.